# December 9, 2025 Issue of JAMA â€” FDA Approves GLP-1 Pill for Cardiovascular Risk in Type 2 Diabetes

**Category:** Health
**Source:** [https://jamanetwork.com/journals/jama/issue/334/22](https://jamanetwork.com/journals/jama/issue/334/22)
**Publisher:** JAMA (Journal of the American Medical Association)
**Published:** 2025-12-09
**Scraped (UTC):** 2025-12-21T06:57:39+00:00

## Summary
The December 9, 2025 JAMA issue reports the FDA approval of a GLP-1 oral medication indicated to reduce cardiovascular risk in people with type 2 diabetes, alongside other clinical and guideline updates.

## Full Article
*(Article text could not be extracted. Visit source link above.)*

---

*Content scraped from public sources with attribution. Users assume all risk.*  
*Auto-generated by [Perplexity News Tracker](https://github.com/myidkd1-coder/perplexity-news-tracker)*